Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure

被引:6
|
作者
Liu, Qi [1 ]
Gao, Juan [2 ]
Deng, Jiali [1 ]
Xiao, Junjie [1 ,2 ]
机构
[1] Shanghai Univ, Inst Cardiovasc Sci, Cardiac Regenerat & Ageing Lab, Sch Life Sci, Shanghai, Peoples R China
[2] Shanghai Univ, Sch Med, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
exercise; muscle; atrophy; therapy; targets; SKELETAL-MUSCLE; RESISTANCE EXERCISE; SATELLITE CELLS; AUTOPHAGY; FITNESS; INTERVENTION; MITOCHONDRIA; INFLAMMATION; ACTIVATION; CAPACITY;
D O I
10.3389/fcvm.2020.593429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Muscle atrophy is a common complication of heart failure. At present, there is no specific treatment to reverse the course of muscle atrophy. Exercise training, due to the safety and easy operation, is a recommended therapy for muscle atrophy induced by heart failure. However, the patients with muscle atrophy are weak in mobility and may not be able to train for a long time. Therefore, it is necessary to explore novel targets of exercise protection for muscle atrophy, so as to improve the quality of life and survival rate of patients with muscular atrophy induced by heart failure. This article aims to review latest studies, summarize the evidence and limitations, and provide a glimpse into the future of exercise for the treatment of muscle atrophy induced by heart failure. We wish to highlight some important findings about the essential roles of exercise sensors in muscle atrophy induced by heart failure, which might be helpful for searching potential therapeutic targets for muscle wasting induced by heart failure.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Continuous Ultrafiltration in Acute Decompensated Heart Failure: Current Issues and Future Directions
    Giancarlo Marenzi
    Marco Morpurgo
    Piergiuseppe Agostoni
    American Journal of Cardiovascular Drugs, 2015, 15 : 103 - 112
  • [32] Continuous Ultrafiltration in Acute Decompensated Heart Failure: Current Issues and Future Directions
    Marenzi, Giancarlo
    Morpurgo, Marco
    Agostoni, Piergiuseppe
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (02) : 103 - 112
  • [33] Current Insights and Future Directions in the Treatment of Heart Failure with Preserved Ejection Fraction
    Chiorescu, Roxana Mihaela
    Lazar, Roxana-Daiana
    Ruda, Alexandru
    Buda, Andreea Paula
    Chiorescu, Stefan
    Mocan, Mihaela
    Blendea, Dan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [34] Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions
    Upadhya, Bharathi
    Kitzman, Dalane W.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (04) : 283 - 298
  • [36] CONTRIBUTION OF SKELETAL-MUSCLE ATROPHY TO EXERCISE INTOLERANCE AND ALTERED MUSCLE METABOLISM IN HEART-FAILURE
    MANCINI, DM
    WALTER, G
    REICHEK, N
    LENKINSKI, R
    MCCULLY, KK
    MULLEN, JL
    WILSON, JR
    CIRCULATION, 1992, 85 (04) : 1364 - 1373
  • [37] Mechanisms and Biomarkers of Exercise-induced Bronchoconstriction Current Insights and Future Directions
    Ameri, Sammy
    Stang, Julie
    Walsted, Emil
    Price, Oliver J.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2025, 45 (01) : 63 - 75
  • [38] Current and future status of stem cell therapy in heart failure
    D'Alessandro D.A.
    Michler R.E.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (6) : 614 - 627
  • [39] Current and Future Directions for Angiosarcoma Therapy
    Vaia Florou
    Breelyn A. Wilky
    Current Treatment Options in Oncology, 2018, 19
  • [40] Current and Future Directions for Angiosarcoma Therapy
    Florou, Vaia
    Wilky, Breelyn A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (03)